Unijules.com

Contrast Media PDF Print E-mail

UROSCAN 60 / 76
(Diatrizoate Meglumine & Diatrizoate Sodium Injection USP)

ANGIOSCAN 65
(Diatrizoate Meglumine Injection USP)


UNIRAY 300 / 370
(Iopamidol Injection USP)

NIOSCAN 240 / 300 / 350
(Iohexol Injection USP)

GASTROSCAN
(Diatrizoate Meglumine & diatrizoate Sodium Oral Solution USP)

MAGNASCAN
(Gadopentetate Dimeglumine Injection USP)
 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Allopathic Range arrow Contrast Media
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.

Download

 

Draft Red Herring Prospectus